Adma Biologics | ADMA - Pre Tax Profit

Stock Price
15.57
Daily Change
0.39 2.57%
Monthly
-4.65%
Yearly
-5.00%
Q1 Forecast
15.60

Adma Biologics reported $47.52M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Adma Biologics USD 47.52M 7.42M Sep/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
BioCryst Pharmaceuticals USD -86.95M 73.5M Dec/2024
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Novavax USD -122.33M 286.92M Sep/2024
Omeros USD -65.12M 21.27M Jun/2024
Takeda JPY 133.86B 105.69B Dec/2025